A clinical study of MixMe by DSM Nutritional Products is said to offer hopes of improving the nutritional status of populations whose diet is severely limited.
A clinical study of MixMe by DSM Nutritional Products is said to offer hopes of improving the nutritional status of populations whose diet is severely limited. MixMe is a multi-micronutrient powder launched in early 2008 in cooperation with the World Food Program. The failure to absorb iron is in part attributable to the diet available to many of the world’s poorest populations, in which whole-grain cereals and legumes figure prominently. These foods contain a naturally occurring anti-nutrient called phytate, which binds minerals, including iron and zinc, and makes them unavailable for absorption by the human body. MixMe provides low doses of a highly absorbable iron and zinc which makes the product suitable for people in malaria-infested areas. The new MixMe formulation used in the study contains a readily bioavailable form of iron (NaFeEDTA) plus an increased vitamin C dose along with a phytase which is active at stomach pH. Phytase is an enzyme that helps to release the digestible nutrients found in grains and oil seeds.
DSM Nutritional Products
011 +41 (0) 61 815 83 54
Clinical Study Looks At MixMe from DSM Nutritional Products
February 24, 2011